Archives of Pharmacal Research

, Volume 28, Issue 1, pp 81–86 | Cite as

Protective effects of chalcone derivatives for acute liver injury in mice

  • Li-Ping Guan
  • Ji-Xing Nan
  • Xue-Jun Jin
  • Qing-Hao Jin
  • Kyung Chell Kwak
  • Kyu-yun Chai
  • Zhe-Shan Quan
Article Drug development

Abstract

The hepatoprotective effects of chalcone derivatives were evaluated in D-galactosamine/ lipopolysaccharide (D-GalN/LPS)-induced fulminant hepatic failure in mouse. Thirteen chalcone derivatives were synthesized for study and their hepatoprotective effects were evaluated by assessing aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels in serum. Chalcone preparations were injected into mice at 12 h and 1 h before intraperitoneal injection of D-GalN/LPS. After abdominal administration, changes in AST and ALT between the control and treated groups were observed. Ten of the synthesized chalcone derivatives exhibited inhibitory effects on D-GalN/LPS-induced levels of AST and ALT in mice. Compounds2, 3, 8, 9, and12 markedly reduced serum AST and ALT at 8 h, inhibited hepatocyte necrosis and showed significant hepatoprotective activities. The activity of compound3 was compared with the bifendate (DDB) through oral administration. Compound3 showed much higher inhibitory effects than bifendate for decreasing AST and ALT activity. The results indicate that compound3 has strong hepatoprotective activity through suppression of tumor necrosis factoralpha (TNF-alpha) preduction, reduction of the histological change in the liver, and attenuated of hepatocyte apoptosis confirmed by DNA fragmentation assay.

Key words

Chalcone derivatives Butein Hepatoprotective activity Fulminant hepatitis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arvelo, M. B., Cooper, J. T., Longo, C., Daniel, S., Grey, S. T., Mahiou, J., Czismadia, E., Abu-jawdeh, G., and Ferran, C., A20 protects mice from D-galactosamine/Lipopolysaccharide acute toxic lethal hepatitis.Hepatol., 35, 535–543 (2002).CrossRefGoogle Scholar
  2. Bekhit, A. A., Habib, N. S., Din, A., and Bekhit, A., Synthesis and antimicrobial evaluation of chalcone and syndrome derivatives of 4(3H)-quinazolinone.Boll. Chim. Farm., 140, 297–301 (2001).PubMedGoogle Scholar
  3. Cheng, Z. J., Kuo, S. C., Chan, S. C., Ko, F. N., and Teng, C. M., Antioxidant properties of butein isolated from Dalbergia odorifera.Biochim. Biophys. Acta, 1392, 291–299 (1998).PubMedGoogle Scholar
  4. Galanos, C., Freudenberg, M. A., and Reutter, W., Galactosamine-induced sensitization to the lethal effects of endotoxin.Proc. Natl. Acad. Sci. U.S.A., 76, 5939–5943 (1979).PubMedCrossRefGoogle Scholar
  5. Hiseh, H. K., Lee, T. H., Wang, J. P., Wang, J. J., and Lin, C. N., Synthesis and anti-inflammatory effects of chalcones and related compounds.Pharm. Res., 15, 39–46 (1998).CrossRefGoogle Scholar
  6. Kosai, K. I., Matsumoto, K., Funakoshi, H., and Nakamura, T., Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice.Hepatol., 30, 151 -159 (1999).CrossRefGoogle Scholar
  7. Kim, K., Kim, Y. M., Park, M., Park, K., Chang, H. K., Park, T. K., Chung, H. H., and Kang, C. Y., A broad spectrum caspase inhibitor blocks concanavalin A-induced hepatitis in mice.Clin. Immunol., 97, 221–233 (2000).PubMedCrossRefGoogle Scholar
  8. Kawaguchi, K., Kikuchi, S., Hasegawa, H., Maruyama, H., Morita, H., and Kumazawa, Y., Suppression of lipopolysaccharideinduced tumor necrosis factor-release and liver injury in mice by naringin.Eur. J. Pharmacol., 368, 245–250 (1999).PubMedCrossRefGoogle Scholar
  9. Kumar, S. K., Hager, E., Pettit, C., Gurulingppa, H., Davidson, N. E., and Khan, S. R., Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agents.J. Med. Chem., 46, 2813–2815 (2003).PubMedCrossRefGoogle Scholar
  10. Kiichiro, K., Seiichi, K., Hirohide, H., Hiroko, M., Hiroyuki, M., and Yoshio, K., Suppression of lipopolysaccharide-induced tumor necrosis factor-release and liver injury in mice by naringin.Eur. J. Pharmacol., 368, 245–250 (1999).CrossRefGoogle Scholar
  11. Lopez, S. N., Castelli, M. V., Zacchino, S. A., Dominguez, J. N., Lobo, G., Chrris-Charriss, J., Cortes, J. C., Ribas, J. C., Devia, C., Rodriguez, A. M., and Enrizz, R. D.,In vitro antifungal evaluation and structure-activity relationships of a new series of chalcone derivatives and synthetic analogues, with inhibitory properties against polymers of the fungal cell wall.Bioorg. Med. Chem., 9, 1999–2013 (2001).PubMedCrossRefGoogle Scholar
  12. Liu, M., Wilairat, P., and Go, M. L., Antimalarial alkoxylated and hydroxylated chalcones [corrected]: structure-activity relationship analysis.J. Med. Chem., 44, 4443–4452 (2001).PubMedCrossRefGoogle Scholar
  13. Mas, A. and Rodes, J., Fulminant hepatic failure.Lancet, 349, 1081–1085 (1997).PubMedCrossRefGoogle Scholar
  14. Murakami, S., Muramatsu, M., Aihara, H., and Otomo, S., Inhibition of gastric H+, K+-ATPase by the antiulcer agent, sofalcone.Biochem. Pharmacol., 42, 1447–1451 (1991).PubMedCrossRefGoogle Scholar
  15. Nakama, T., Hirono, S., Moriuchi, A., Hasuike, S., Nagata, K., Hori, T., Ido, A., Hayashi, K., and Tsubouchi, H., Etoposide prevents apoptosis in mouse liver with D-galactosamine/ lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality.Hepatol., 33, 1441–1450 (2001).CrossRefGoogle Scholar
  16. Sass, G., Heinlein, S., Agli, A., Bang, R., Schümann, J., and Tiegs, G., Cytokine expression in three mouse models of experimental hepatitis.Cytokine, 19, 115–120 (2002).PubMedCrossRefGoogle Scholar
  17. Morikawa, T., Matsuda, H., Ninomiya, K., and Yoshikawa, M., Medicinal Foodstuffs XXIX. Potent protective effects of sesquiterpenes and curcumin from zedoariae rhizoma on liver injury induced by D-galactosamine/Lipopolysaccharide or tumor necrosis factor-α.Biol. Pharm. Bull., 25, 627–631 (2002).PubMedCrossRefGoogle Scholar
  18. Takahashi, K., Morikawa, A., Kato, Y., Sugiyama, T., Koide, N., Mu, M. M., Yoshida, T., and Yokochi, T., Flavonoids protect mice from two types of lethal shock induced by endotoxin.FEMS. Immunol. Med. Microbiol., 31, 29–33 (2001).PubMedCrossRefGoogle Scholar
  19. Tran, Q. L., Adnyana, I. K., Tezuka, Y., Harimaya, Y., Saiki, I., Kurashige, Y., Tran, Q. K., and Kadota, S., Hepatoprotective effect of majonoside R2, the major saponin from Vietnamese ginseng.Planta Med., 68, 402–406 (2002).PubMedCrossRefGoogle Scholar
  20. Viana, G. S., Bandeira, M. A., and Matos, F. J., Analgesic and antiinflammatory effects of chalcones isolated from Myracrodruon urundeuva allemao.Phytomedicine, 10, 189–196 (2003).PubMedCrossRefGoogle Scholar
  21. Wu, J. H., Wang, X. H., Yi, Y. H., and Lee, K. H., Anti-AIDS agents 54, A potent anti-HIV chalcone and flavonoids from genus Desmos.Bioorg. Med. Chem. Lett., 13, 1813–1815 (2003).PubMedCrossRefGoogle Scholar
  22. Woo, S. W., Lee, S. H., Kang, H. C., Park, E. J., Zhao, Y. Z., Kim, Y. C., and Sohn, D. H., Butein suppresses myofibroblastic differentiation of rat-hepatic stellate cells in primary culture.J. Pharm. Pharmacol., 55, 347–352 (2003).PubMedCrossRefGoogle Scholar
  23. Xiong, Q., Hase, K., Tezuka, Y., Namba, T., and Kadota, S., Acteoside inhibits apoptosis in D-galactosamine and lipopolysaccharide-induced liver injury.Life Sci., 65, 421–430 (1999).PubMedCrossRefGoogle Scholar

Copyright information

© The Pharmaceutical Society of Korea 2005

Authors and Affiliations

  • Li-Ping Guan
    • 1
  • Ji-Xing Nan
    • 1
  • Xue-Jun Jin
    • 1
  • Qing-Hao Jin
    • 1
  • Kyung Chell Kwak
    • 2
    • 1
  • Kyu-yun Chai
    • 2
    • 1
  • Zhe-Shan Quan
    • 1
  1. 1.College of PharmacyYan bian UniversityYanji City, Jilin ProvinceP.R. China
  2. 2.Department of ChemistryWonkwang UniversityIksanKorea

Personalised recommendations